A revamp of Hong Kong’s listing rules will allow biotechnology firms that do not have a profit track-record to float their shares. Photo: AFP

Delisted in Taiwan, drug maker is looking to raise funds on Hong Kong’s exchange

Topic |   IPO

TOP PICKS

A revamp of Hong Kong’s listing rules will allow biotechnology firms that do not have a profit track-record to float their shares. Photo: AFP
READ FULL ARTICLE